HCP Live

NCCN 2010: Dr. Mark Kris, Memorial Sloan-Kettering Cancer Center

Mar 17, 2010

Mark G. Kris, MD of the Memorial Sloan-Kettering Cancer Center speaks about Maintenance Therapy for Non-Small Cell Lung Cancer at the 15th Annual NCCN Conference in Hollywood, FL March, 2010.

Related Videos

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care

Victor-Kim-MD

Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development

Panagis Galiatsatos, MD: Closing the Gap in Lung Cancer Screening

Antonio Anzueto, MD: Advancing Triple-Therapy Inhalers for COPD

Panagis Galiatsatos, MD

Related Content

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Autoimmune Disease Diagnosis Increasing in the UK

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

COVID-19 Vaccination Safe for Pregnant Women with Autoimmune Disorders

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Autoimmune Disease Diagnosis Increasing in the UK

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

COVID-19 Vaccination Safe for Pregnant Women with Autoimmune Disorders

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Autoimmune Disease Diagnosis Increasing in the UK

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

COVID-19 Vaccination Safe for Pregnant Women with Autoimmune Disorders

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

Related Content

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

Live From ATS 2023 with Anne Dixon, MD

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Autoimmune Disease Diagnosis Increasing in the UK

Autoimmune Disease Diagnosis Increasing in the UK

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

COVID-19 Vaccination Safe for Pregnant Women with Autoimmune Disorders

COVID-19 Vaccination Safe for Pregnant Women with Autoimmune Disorders

Brian LaMoreaux, MD, MS | Credit: Horizon Therapeutics

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.